Abstract:Histone deacetylases (HDACs)-mediated epigenetic mechanisms play critical roles in the homeostasis of histone acetylation and gene transcription. HDAC inhibitors have displayed neuroprotective properties in animal models for various neurological diseases including Alzheimer's disease and ischaemic stroke. However, some studies have also reported that HDAC enzymes exert protective effects in several pathological conditions including ischaemic stress. The mixed results indicate the specific roles of each HDAC protein in different diseased states. However, the subtypes of HDACs associated with ischaemic stroke keep unclear. Therefore, in this study, we used an in vivo middle cerebral artery occlusion (MCAO) model and in vitro cell cultures by the model of oxygen glucose deprivation to investigate the expression patterns of HDACs and explore the roles of individual HDACs in ischaemic stroke. Our results showed that inhibition of NADPH oxidase activity ameliorated cerebral ischaemia/reperfusion (I/R) injury and among Zn2+-dependent HDACs, HDAC4 and HDAC5 were significantly decreased both in vivo and in vitro, which can be reversed by NADPH oxidase inhibitor apocynin. We further found that both HDAC4 and HDAC5 increased cell viability through inhibition of HMGB1, a central mediator of tissue damage following acute injury, expression and release in PC12 cells. Our results for the first time provide evidence that NADPH oxidase-mediated HDAC4 and HDAC5 expression contributes to cerebral ischaemia injury via HMGB1 signalling pathway, suggesting that it is important to elucidate the role of individual HDACs within the brain, and the development of HDAC inhibitors with improved specificity is required to develop effective therapeutic strategies to treat stroke.

Role of Phosphorylated HDAC4 in Stroke-Induced Angiogenesis

HDAC4 in Ischemic Stroke: Mechanisms and Therapeutic Potential

HDAC9 Deficiency Upregulates Cgmp-Dependent Kinase II to Mitigate Neuronal Apoptosis in Ischemic Stroke

HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury.

HDAC1 deregulation promotes neuronal loss and deficit of motor function in stroke pathogenesis

Effects of PDE4 pathway inhibition in rat experimental stroke.

PDE4 regulates tissue plasminogen activator expression of human brain microvascular endothelial cells.

HDAC3 Contributes to Ischemic Stroke by Regulating Interferon Pathway

Therapeutic application of histone deacetylase inhibitors for stroke.

Restoration of HDAC1 Enzymatic Activity after Stroke Protects Neurons from Ischemia/Reperfusion Damage and Attenuates Behavioral Deficits in Rats

Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage.

Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection.

Interleukin-4 Regulation on Angiogenesis in Ischemic Stroke

Inhibition Of Histone Deacetylase 3 By Mir-494 Alleviates Neuronal Loss And Improves Neurological Recovery In Experimental Stroke

Silencing of microRNA-494 inhibits the neurotoxic Th1 shift via regulating HDAC2-STAT4 cascade in ischaemic stroke

Angiopoietin-like 4: A Double-Edged Sword in Atherosclerosis and Ischemic Stroke?

Neuroprotective Mechanisms of Histone Deacetylase Inhibitors in Ischemic Stroke

Molecular Imaging Reveals Antineuroinflammatory Effects of HDAC6 Inhibition in Stroke Models

HDAC9 in the Injury of Vascular Endothelial Cell Mediated by P38 MAPK Pathway.

Hypoxia Inducible Factor-1α Attenuates Ischemic Brain Damage by Modulating Inflammatory Response and Glial Activity.

Early Histone Deacetylase Inhibition Mitigates Ischemia/Reperfusion Brain Injury by Reducing Microglia Activation and Modulating Their Phenotype